ArticleBMC microbiology2026
Analysis of clinical characteristics and whole-genome sequencing of carbapenem-resistant Acinetobacter baumannii isolates from pediatric patients in Guangxi, China.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antimicrobial Resistance and Virulence ofAntibiotics (Basel, Switzerland) · 2026Article
- Genomic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCarbapenem-resistant Acinetobacter baumannii (CRAB) is an urgent global threat and has been designated as a priority pathogen.
methodsWe conducted a retrospective study of pediatric patients with CRAB infection at a Maternal and Child Health Hospital in Guangxi, China, from January 2019 to December 2024. The bacterial isolates were then subjected to antimicrobial susceptibility testing (AST) and whole-genome sequencing (WGS).
resultsA total of 132 pediatric patients with CRAB infections were included in this study (83 with positive outcomes and 49 with negative outcomes). AST revealed that all CRAB isolates were multidrug-resistant (MDR). Polymyxin B (99.2% susceptible), minocycline (68.9%), and cefoperazone-sulbactam (65.2%) demonstrated the highest susceptibility rates among the antibiotics tested. WGS revealed that the most prevalent strain was ST2
conclusionsThis study details the clinical and molecular features of CRAB infections in pediatric patients in Guangxi, China. Pediatric infection control should be highly alert to the emergence of ST1208
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.